Serial #79406989
LIVE

Serial Number

79406989

Owner

PNEOO B.V.

Attorney

Cheryl L. Burbach

Filing Date

Aug 8, 2024

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79406989 Trademark

Serial Number: 79406989 • Registration: 7910333

Serial #79406989 is a trademark filed by PNEOO B.V. on August 8, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

PNEOO B.V. (3 trademarks)

Commerdaelseweg 8

Entity Type: 26

Trademark Details

Filing Date

August 8, 2024

Registration Date

August 26, 2025

Published for Opposition

July 8, 2025

Goods & Services

Medical, biological, and pharmaceutical preparations for the treatment of pulmonary diseases; veterinary preparations for pulmonary diseases; medical, biological, and pharmaceutical preparations for preventing and treating infectious diseases, medical disorders, and diseases, namely, lung cancer; veterinary preparations for pets, cattle, livestock for preventing and treating infectious diseases, medical disorders, and diseases, namely, lung cancer; medical, biological, and pharmaceutical preparations for preventing and treating viral, bacterial, and yeast infections; veterinary preparations for pets, cattle, livestock for preventing and treating viral, bacterial, and yeast infections; medical, biological, and pharmaceutical preparations for preventing and treating cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; veterinary preparations for pets, cattle, livestock for preventing and treating cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, ontological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; regulatory proteins for medical use, namely, protein arrays for medical diagnosis purposes; pharmaceutical compounds being a component in pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the prevention of diseases of the respiratory system; diagnostic preparations for medical purposes; chemical diagnostic reagents for medical use

Custom manufacture of pharmaceuticals; custom manufacture of pharmaceuticals, biopharmaceuticals and vaccines in relation to cell therapy, gene editing, protein replacement, and antibodies; provision of information, advice and consultancy services in the field of the aforesaid services

Biological research; clinical research in the field of respiratory diseases, pulmonary diseases, pulmonary surgery; medical research; research and development services in the field of pharmaceutical preparations; pharmaceutical products development; pharmaceutical product evaluation; research in the field of pharmaceuticals; testing of pharmaceuticals; pharmaceutical and medical research and development services in the field of various medical disorders, cancer, pulmonary diseases and infectious diseases; vaccine research and development services; research and development in the field of microorganisms and cells; development of gene-based medicines; drug discovery services; conducting clinical trials for pharmaceutical products for others; scientific laboratory services; laboratory research services relating to pharmaceuticals; Consultancy in the field of pharmaceutical research; Scientific Research services in the nature of conduction clinical trials for others for assessing the efficiency of pharmaceuticals; chemical research and analysis services; medical research and development services in the field of respiratory diseases, pulmonary diseases, cancer; pharmacological research services; scientific research and development in the field of respiratory diseases, pulmonary diseases, cancer; scientific research in the field of respiratory diseases, pulmonary diseases, cancer for medical purposes; scientific research for medical purposes in the area of diseases; conducting clinical trials for others; scientific research in the field of genetics and genetic engineering; genetic research; genetic mapping for scientific purposes; DNA screening for scientific research purposes; DNA analysis services for scientific research purposes; providing scientific information in the field of medical disorders and their treatment; biotechnological research relating to enzymatic synthesis; technical research in the field of pharmaceutical studies; toxicity testing for scientific research purposes; toxicity analysis; information technology services in the nature of on-site management of information technology (IT) systems of others for the pharmaceutical and healthcare industries; Pharmaceutical product evaluation, namely, conducting early evaluations in the field of new pharmaceuticals; providing scientific information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; design and development of computer software relating to the medical field; design and development of computer software relating to healthcare; software as a service (SaaS) featuring artificial intelligence software for healthcare; Software as a service (SaaS) featuring software relating to the medical field; Veterinary research; Provision of information and data relating to medical and veterinary research and development

Biological preparations for use in cell cultures, other than for medical or veterinary purposes, for boosting cells in the immune system for improved therapies; biological preparations for use in cell cultures, in the nature of genetically modified cells and vectors for scientific and research purposes; biological and chemical reagents in the nature of complexes of molecules for scientific research and for clinical and industrial use; proteins for use in scientific research; regulatory proteins in raw material for scientific research

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 23, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 23, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 23, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 23, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 23, 2026 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 2, 2026 FINO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 2, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 16, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 16, 2026 OPNR
FINAL DISPOSITION NOTICE SENT TO IB
Mar 14, 2026 FICS
FINAL DISPOSITION PROCESSED
Mar 14, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 26, 2025 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Nov 14, 2025 NREP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 26, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 26, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 8, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 8, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 2, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 7, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 5, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 5, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 5, 2025 TROA
REFUSAL PROCESSED BY IB
Apr 12, 2025 RFNT
NEW REPRESENTATIVE AT IB RECEIVED
Mar 28, 2025 NREP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 27, 2025 RFCS
REFUSAL PROCESSED BY MPU
Mar 27, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 21, 2025 RFCR
NON-FINAL ACTION WRITTEN
Feb 20, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 13, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 22, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 22, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 17, 2024 REPR